SlideShare a Scribd company logo
1 of 1
MANSI CHAUHAN & AMBER PRUITT-RIGGINS
BIOMEDICAL AND HEALTH INFORMATION SCIENCES, UNIVERSITY OF ILLINOIS AT CHICAGO, SPRING 2016
MULTIPLE CHRONIC CONDITIONS: COST, MORTALITY & RACE
As the prevalence of multiple chronic conditions (MCC) rises, its
association with higher healthcare expenditures and lower patient
outcomes becomes a growing concern. This intensifies the need for
more research exploring the impact of MCC on hospital costs and
quality and examining demographic variations. The purpose of this
study was to determine whether there are cost, mortality, and race
variations among hospitalized patients with MCC. The data set of 788
cases was randomly selected from the Healthcare Cost and Utilization
Project (HCUP) National Inpatient Sample (NIS) 2012. IBM SPSS
Version 23 was used to conduct secondary data analysis. Independent
samples t-test results indicated there was a significant difference in
average total charges between inpatients with 1-4 chronic conditions
(CC) and 5+ CC. Chi-square test results showed no association in
death during hospitalization among inpatients with 1-4 CC and 5+ CC
and also no association between Hispanic and Black race among
inpatients with 5+ CC. Despite that these findings showed no
significant results in mortality and race, they do support the trend of
higher healthcare costs among inpatients with MCC. Given the need
to control hospital costs, further exploration of variation in charges
and of factors that may be related to MCC among inpatients is
recommended.
DISCUSSION
The results indicated that average total charges for inpatients
with 5+ CC were significantly higher than those with 1-4 CC, which
complemented previous research. While the Chi-square test results
indicated that deaths were higher for inpatients with 5+ CC than 1-4
CC, there was no significant association. Likewise, while 5+ CC was
more prevalent among Black inpatients than Hispanic inpatients,
there was no significant association. These results were inconsistent
with previous research, which indicated a significant association
between Hispanic and Black race among patients with MCC.
The results in this research may be limited due to a small
dataset, which may not have accurately represented the entire
population. Inconsistencies may also have been caused by comparing
different groups of MCC than previous research. This research
grouped MCC into 1-4 CC and 5+ CC, while other research compared
groups, such as 2-3 CC and 4+ CC.
SAMPLE
• Source: Healthcare Cost and Utilization Project (HCUP) National
Inpatient Sample (NIS) 2012 - 20% sample of discharges from all
inpatient hospitals participating in HCUP (excludes rehabilitation and
long term care)
• Sampling: random sampling stratified by U.S. Census Division
• Data set: randomly selected from NIS 2012
• Project sample limited for assignment - 788 cases with 1+ CC
METHODS
• Quantitative research using secondary data analysis - data processed
using IBM SPSS Version 23
• Descriptive statistics, independent samples t-test, and Chi-square
used to analyze data
• Confidence level = 95%, alpha level = 0.05 for significance testing
S A M P L E / M E T H O D S
Friedman, B., & Steiner, C. (2013) Hospital Utilization, Costs, and Mortality for
Adults With Multiple Chronic Conditions, Nationwide Inpatient Sample,
2009. Preventing Chronic Disease, 10, E62. Retrieved from
http://www.ncbi.nlm.nih.gov.proxy.cc.uic.edu/pmc/articles/PMC3652722
HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project
(HCUP). (2012). Agency for Healthcare Research and Quality, Rockville, MD.
Retrieved from http://www.hcup-us.ahrq.gov/nisoverview.jsp
Jiang H. J., Weiss A.J., Barrett M.L., Sheng M. (2015) Characteristics of Hospital
Stays for Super-Utilizers by Payer, 2012. HCUP Statistical Brief #190. Agency
for Healthcare Research and Quality, Rockville, MD. Retrieved from
http://www.hcup-us.ahrq.gov/reports/statbriefs/sb190-Hospital-Stays-Super-
Utilizers-Payer-2012.pdf
Steiner C., Barrett M., Weiss A., & Andrews R. (2014) Trends and Projections in
Hospital Stays for Adults With Multiple Chronic Conditions (MCC), 2003–
2014. HCUP Statistical Brief #183. Agency for Healthcare Research and
Quality. Retrieved from http://www.hcup-
us.ahrq.gov/reports/statbriefs/sb183-Hospitalizations-Multiple-Chronic-
Conditions-Projections-2014.pdf
Ward B. W., & Schiller J. S. (2013) Prevalence of Multiple Chronic Conditions
Among US Adults: Estimates From the National Health Interview Survey,
2010. Preventing Chronic Disease, 10. 120203. Retrieved from
http://www.cdc.gov/Pcd/issues/2013/12_0203.htm
P U R P O S E / H Y P OT H E S E S
PURPOSE The purpose of this research is to determine whether there are
variations in cost of care and mortality rates among inpatients with multiple
chronic conditions (MCC) discharged from acute care hospitals in the U.S. in
2012. This research will also determine if there are racial disparities among
inpatients with MCC.
RESEARCH QUESTION Are there cost, mortality rate, and race variations
among inpatients with MCC?
HYPOTHESES
• H0: There is no difference in average total charges between inpatients with 1-
4 CC and those with 5 or more CC among discharges from acute care hospitals
in the U.S. in 2012.
• H1: There is a difference in average total charges between inpatients with 1-4
CC and those with 5 or more CC among discharges from acute care hospitals in
the U.S. in 2012.
• H0: There is no association in death during hospitalization between inpatients
with 1-4 CC and those with 5 or more CC among discharges from acute care
hospitals in the U.S. in 2012.
• H2: There is an association in death during hospitalization between inpatients
with 1-4 CC and those with 5 or more CC among discharges from acute care
hospitals in the U.S. in 2012.
• H0: There is no association between Hispanic and Black inpatients with 5 or
more CC discharged from acute care hospitals in the U.S. in 2012.
• H3: There is an association between Hispanic and Black inpatients with 5 or
more CC discharged from acute care hospitals in the U.S. in 2012.
MCC
1-4, 5+ CC
RACE
HISPANIC/BLACK
DEATH
DURING
HOSPITALIZATION
TOTAL
CHARGES
MEAN PER
GROUP
A B S T R A C T
M O D E L
D I S C U S S I O N / C O N C LU S I O NB A C KG R O U N D
R E F E R E N C E S
R E S U LT S
The prevalence of patients with multiple chronic conditions (MCC) has
continuously increased over time and is present in twenty-five percent of
Americans adults (Steiner et al., 2014). MCC refers to the existence of two
or more chronic conditions that affect a patient simultaneously. The
presence of MCC has been seen to impact multiple areas in healthcare,
including quality and cost of care. Demographic variations, including race,
have also been observed among those with MCC. The following trends were
found in previous studies:
• Higher healthcare expenditures among those with MCC than those
without MCC, contributed by:
• Greater percentage of hospital stays
• More expensive hospital stays (Steiner et al., 2014)
• Higher mortality rates among those with MCC than those without MCC
(Friedman & Steiner, 2013)
• Higher prevalence of MCC among non-Hispanic black adults compared to
Hispanic adults (Ward & Schiller, 2013)
These findings are significant as healthcare expenditures among those
with MCC have been increasing over time (Steiner et al., 2014). With the
continuous increase in patients with MCC, hospital mortality rates may
follow the same pattern. Thus, studying these areas may help to find
variations among those with MCC. Also, if racial disparities are found,
further research can be done to determine their causes. Discovering
variations will allow appropriate action to be taken, helping to regulate
healthcare costs and patient outcomes.
6
12
0
2
4
6
8
10
12
14
1-4 CC 5+ CC
NUMBEROFPATIENTDEATHS
$32,416
$44,794
$0
$5,000
$10,000
$15,000
$20,000
$25,000
$30,000
$35,000
$40,000
$45,000
$50,000
1-4 CC 5+ CC
AVERAGETOTALCHARGES
A V E R A G E T O T A L C H A R G E S
P E R G R O U P
H I S P A N I C V S . B L A C K
I N P A T I E N T S W I T H 5 + C C
D E A T H S P E R G R O U P
TEST INDEPENDENT SAMPLES T-TEST CHI-SQUARE TEST CHI-SQUARE TEST
P-VALUE 0.002 0.317 0.352
RESULT P<0.05, reject H0 P>0.05, fail to reject H0 P>0.05, fail to reject H0
CONCLUSION There is a difference in average total
charges between inpatients with 1-4
CC and those with 5+ CC.
There is no association in death during
hospitalization between inpatients with
1-4 CC and those with 5+ CC.
There is no association between Hispanic
and Black inpatients with 5 or more CC.
29
49
0
10
20
30
40
50
60
HISPANIC BLACK
NUMBEROFPATIENTS
A C K N O W L E D G E M E N T S
This project was supported by the College of Applied Health
Sciences. Special thanks to Professor Valerie Prater, MBA, RHIT,
FAHIMA and instructor Shaheen Khan, MS, MBA, MPH.
CONCLUSION
Overall, the findings in this research were significant despite
inconsistencies. This research supported previous findings of a
higher cost burden among those with MCC. Costs for patients with
MCC are “20 percent more on average” than those without MCC
(Steiner et al., 2014). Furthermore, a large proportion of healthcare
costs are incurred by a small group of patients, many of which have
MCC (Jiang et al., 2015). Thus, it is imperative to find reasons for
rising MCC cases as a means to control costs. Despite that this
research showed no significant results in mortality and race, further
research is recommended. Exploration into the cause of rising MCCs
among patients, and into the cost-benefit of continuing
reimbursement incentives for documentation of MCCs, present
opportunities to reduce growing healthcare expenditures.

More Related Content

What's hot

Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial DyslipidemiaLipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial DyslipidemiaGlobal Medical Cures™
 
JMCP 2016 Access to new meds for hep C in Medicaid members
JMCP 2016  Access to new meds for hep C in Medicaid membersJMCP 2016  Access to new meds for hep C in Medicaid members
JMCP 2016 Access to new meds for hep C in Medicaid membersKimberly Lenz
 
Crimson Publishers-Natural Products for Psoriasis
Crimson Publishers-Natural Products for PsoriasisCrimson Publishers-Natural Products for Psoriasis
Crimson Publishers-Natural Products for PsoriasisCrismonPublishersCJSH
 
Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...
Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...
Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...CrimsonpublishersCancer
 
BSCThesis_11324066
BSCThesis_11324066BSCThesis_11324066
BSCThesis_11324066Marie Murphy
 
Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...
Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...
Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...Real Wellness, LLC
 
Assessment of cardiovascular disease risk among qatari patients with type 2 p...
Assessment of cardiovascular disease risk among qatari patients with type 2 p...Assessment of cardiovascular disease risk among qatari patients with type 2 p...
Assessment of cardiovascular disease risk among qatari patients with type 2 p...Dr. Anees Alyafei
 
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...National Alopecia Areata Foundation
 
Journal club pediatrics medicine
Journal club pediatrics medicineJournal club pediatrics medicine
Journal club pediatrics medicineNehal Shah
 

What's hot (14)

Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial DyslipidemiaLipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
Lipid Screening in Childhood for Detection of Multifactorial Dyslipidemia
 
JMCP 2016 Access to new meds for hep C in Medicaid members
JMCP 2016  Access to new meds for hep C in Medicaid membersJMCP 2016  Access to new meds for hep C in Medicaid members
JMCP 2016 Access to new meds for hep C in Medicaid members
 
THRIVE-stm2016-2
THRIVE-stm2016-2THRIVE-stm2016-2
THRIVE-stm2016-2
 
Crimson Publishers-Natural Products for Psoriasis
Crimson Publishers-Natural Products for PsoriasisCrimson Publishers-Natural Products for Psoriasis
Crimson Publishers-Natural Products for Psoriasis
 
Austin Biometrics and Biostatistics
Austin Biometrics and BiostatisticsAustin Biometrics and Biostatistics
Austin Biometrics and Biostatistics
 
Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...
Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...
Multidisciplinary Approach to Prostate Cancer and Changes in Treatment Decisi...
 
BSCThesis_11324066
BSCThesis_11324066BSCThesis_11324066
BSCThesis_11324066
 
Physician shortage in canada
Physician shortage   in canadaPhysician shortage   in canada
Physician shortage in canada
 
Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...
Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...
Hepatitis C Risk Assessment, Testing and Referral for Treatment in primary Ca...
 
AE poster
AE posterAE poster
AE poster
 
Assessment of cardiovascular disease risk among qatari patients with type 2 p...
Assessment of cardiovascular disease risk among qatari patients with type 2 p...Assessment of cardiovascular disease risk among qatari patients with type 2 p...
Assessment of cardiovascular disease risk among qatari patients with type 2 p...
 
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
 
5.14.11.public health
5.14.11.public health5.14.11.public health
5.14.11.public health
 
Journal club pediatrics medicine
Journal club pediatrics medicineJournal club pediatrics medicine
Journal club pediatrics medicine
 

Viewers also liked

Why Wellness
Why WellnessWhy Wellness
Why Wellnessdrtroy
 
Structural Trauma and Toxic Stress: Lifecourse Roots of Health Inequities
Structural Trauma and Toxic Stress: Lifecourse Roots of Health InequitiesStructural Trauma and Toxic Stress: Lifecourse Roots of Health Inequities
Structural Trauma and Toxic Stress: Lifecourse Roots of Health InequitiesTomas J. Aragon
 
4 18-2013 chicago-chronic disease management
4 18-2013 chicago-chronic disease management4 18-2013 chicago-chronic disease management
4 18-2013 chicago-chronic disease managementC Sam Smith
 
Tackling health inequities by focusing on structural determinants
Tackling health inequities by focusing on structural determinantsTackling health inequities by focusing on structural determinants
Tackling health inequities by focusing on structural determinantsJim Bloyd
 
Policy Development to Tackle Structural Origins of Health Inequities: Thought...
Policy Development to Tackle Structural Origins of Health Inequities: Thought...Policy Development to Tackle Structural Origins of Health Inequities: Thought...
Policy Development to Tackle Structural Origins of Health Inequities: Thought...Jim Bloyd
 
Groups Experiencing Inequities
Groups Experiencing InequitiesGroups Experiencing Inequities
Groups Experiencing Inequitiespdhpemag
 

Viewers also liked (7)

Why Wellness
Why WellnessWhy Wellness
Why Wellness
 
ChronicBoom_Part_1
ChronicBoom_Part_1ChronicBoom_Part_1
ChronicBoom_Part_1
 
Structural Trauma and Toxic Stress: Lifecourse Roots of Health Inequities
Structural Trauma and Toxic Stress: Lifecourse Roots of Health InequitiesStructural Trauma and Toxic Stress: Lifecourse Roots of Health Inequities
Structural Trauma and Toxic Stress: Lifecourse Roots of Health Inequities
 
4 18-2013 chicago-chronic disease management
4 18-2013 chicago-chronic disease management4 18-2013 chicago-chronic disease management
4 18-2013 chicago-chronic disease management
 
Tackling health inequities by focusing on structural determinants
Tackling health inequities by focusing on structural determinantsTackling health inequities by focusing on structural determinants
Tackling health inequities by focusing on structural determinants
 
Policy Development to Tackle Structural Origins of Health Inequities: Thought...
Policy Development to Tackle Structural Origins of Health Inequities: Thought...Policy Development to Tackle Structural Origins of Health Inequities: Thought...
Policy Development to Tackle Structural Origins of Health Inequities: Thought...
 
Groups Experiencing Inequities
Groups Experiencing InequitiesGroups Experiencing Inequities
Groups Experiencing Inequities
 

Similar to Project 9 Poster SRF

Cross the Finish Line First
Cross the Finish Line FirstCross the Finish Line First
Cross the Finish Line FirstVitreosHealth
 
HASA and HHC COBRA Pilot Report 2006
HASA and HHC COBRA Pilot Report 2006HASA and HHC COBRA Pilot Report 2006
HASA and HHC COBRA Pilot Report 2006Aquilino Gabor
 
PPT with Critical appraisal
PPT with Critical appraisalPPT with Critical appraisal
PPT with Critical appraisalEka Kurniawan
 
Reducing Readmissions and Length of Stay
Reducing Readmissions and Length of StayReducing Readmissions and Length of Stay
Reducing Readmissions and Length of StayVITAS Healthcare
 
My Research Projects
My Research ProjectsMy Research Projects
My Research Projectsrpunekar
 
Patient Portals and Multimedia Reports
Patient Portals and Multimedia ReportsPatient Portals and Multimedia Reports
Patient Portals and Multimedia ReportsThiago Julio, MD
 
Sepsis Report - Diagnosis and Treatment
Sepsis Report - Diagnosis and TreatmentSepsis Report - Diagnosis and Treatment
Sepsis Report - Diagnosis and TreatmentBostonsp
 
Pathophysiology Of Heart Failure
Pathophysiology Of Heart FailurePathophysiology Of Heart Failure
Pathophysiology Of Heart FailureStephanie King
 
JACM-D-13-00014proof
JACM-D-13-00014proofJACM-D-13-00014proof
JACM-D-13-00014proofLucas Pauls
 
HIVProjectProgressPoster[1]
HIVProjectProgressPoster[1]HIVProjectProgressPoster[1]
HIVProjectProgressPoster[1]Mary Beth Levin
 
Determine the Patients' Satisfaction Concerning In-hospital Information Progr...
Determine the Patients' Satisfaction Concerning In-hospital Information Progr...Determine the Patients' Satisfaction Concerning In-hospital Information Progr...
Determine the Patients' Satisfaction Concerning In-hospital Information Progr...iosrjce
 
CHAPTER IV- DATA AND ANALYSISIntroductionBased on the collec
CHAPTER IV- DATA AND ANALYSISIntroductionBased on the collecCHAPTER IV- DATA AND ANALYSISIntroductionBased on the collec
CHAPTER IV- DATA AND ANALYSISIntroductionBased on the collecJinElias52
 
Evidence TableEvidence TablePICOT Question[Insert here]APA Sourc
Evidence TableEvidence TablePICOT Question[Insert here]APA SourcEvidence TableEvidence TablePICOT Question[Insert here]APA Sourc
Evidence TableEvidence TablePICOT Question[Insert here]APA SourcBetseyCalderon89
 
NURS 412 Incivility in Nursing Practice in a Hospital.pdf
NURS 412 Incivility in Nursing Practice in a Hospital.pdfNURS 412 Incivility in Nursing Practice in a Hospital.pdf
NURS 412 Incivility in Nursing Practice in a Hospital.pdfbkbk37
 

Similar to Project 9 Poster SRF (20)

Cross the Finish Line First
Cross the Finish Line FirstCross the Finish Line First
Cross the Finish Line First
 
5.14.11.public health
5.14.11.public health5.14.11.public health
5.14.11.public health
 
5.14.11.public health
5.14.11.public health5.14.11.public health
5.14.11.public health
 
5.14.11.public health
5.14.11.public health5.14.11.public health
5.14.11.public health
 
HASA and HHC COBRA Pilot Report 2006
HASA and HHC COBRA Pilot Report 2006HASA and HHC COBRA Pilot Report 2006
HASA and HHC COBRA Pilot Report 2006
 
PPT with Critical appraisal
PPT with Critical appraisalPPT with Critical appraisal
PPT with Critical appraisal
 
Reducing Readmissions and Length of Stay
Reducing Readmissions and Length of StayReducing Readmissions and Length of Stay
Reducing Readmissions and Length of Stay
 
My Research Projects
My Research ProjectsMy Research Projects
My Research Projects
 
Patient Portals and Multimedia Reports
Patient Portals and Multimedia ReportsPatient Portals and Multimedia Reports
Patient Portals and Multimedia Reports
 
Sepsis Report - Diagnosis and Treatment
Sepsis Report - Diagnosis and TreatmentSepsis Report - Diagnosis and Treatment
Sepsis Report - Diagnosis and Treatment
 
Pathophysiology Of Heart Failure
Pathophysiology Of Heart FailurePathophysiology Of Heart Failure
Pathophysiology Of Heart Failure
 
JACM-D-13-00014proof
JACM-D-13-00014proofJACM-D-13-00014proof
JACM-D-13-00014proof
 
HIVProjectProgressPoster[1]
HIVProjectProgressPoster[1]HIVProjectProgressPoster[1]
HIVProjectProgressPoster[1]
 
HJS_HIVSurveyProject
HJS_HIVSurveyProjectHJS_HIVSurveyProject
HJS_HIVSurveyProject
 
Determine the Patients' Satisfaction Concerning In-hospital Information Progr...
Determine the Patients' Satisfaction Concerning In-hospital Information Progr...Determine the Patients' Satisfaction Concerning In-hospital Information Progr...
Determine the Patients' Satisfaction Concerning In-hospital Information Progr...
 
CHAPTER IV- DATA AND ANALYSISIntroductionBased on the collec
CHAPTER IV- DATA AND ANALYSISIntroductionBased on the collecCHAPTER IV- DATA AND ANALYSISIntroductionBased on the collec
CHAPTER IV- DATA AND ANALYSISIntroductionBased on the collec
 
Evidence TableEvidence TablePICOT Question[Insert here]APA Sourc
Evidence TableEvidence TablePICOT Question[Insert here]APA SourcEvidence TableEvidence TablePICOT Question[Insert here]APA Sourc
Evidence TableEvidence TablePICOT Question[Insert here]APA Sourc
 
Nursing capstone project writing service
Nursing capstone project writing serviceNursing capstone project writing service
Nursing capstone project writing service
 
How the CCP Model Could Ensure Better Patient Care & Reduced Costs
How the CCP Model Could Ensure Better Patient Care & Reduced CostsHow the CCP Model Could Ensure Better Patient Care & Reduced Costs
How the CCP Model Could Ensure Better Patient Care & Reduced Costs
 
NURS 412 Incivility in Nursing Practice in a Hospital.pdf
NURS 412 Incivility in Nursing Practice in a Hospital.pdfNURS 412 Incivility in Nursing Practice in a Hospital.pdf
NURS 412 Incivility in Nursing Practice in a Hospital.pdf
 

Project 9 Poster SRF

  • 1. MANSI CHAUHAN & AMBER PRUITT-RIGGINS BIOMEDICAL AND HEALTH INFORMATION SCIENCES, UNIVERSITY OF ILLINOIS AT CHICAGO, SPRING 2016 MULTIPLE CHRONIC CONDITIONS: COST, MORTALITY & RACE As the prevalence of multiple chronic conditions (MCC) rises, its association with higher healthcare expenditures and lower patient outcomes becomes a growing concern. This intensifies the need for more research exploring the impact of MCC on hospital costs and quality and examining demographic variations. The purpose of this study was to determine whether there are cost, mortality, and race variations among hospitalized patients with MCC. The data set of 788 cases was randomly selected from the Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample (NIS) 2012. IBM SPSS Version 23 was used to conduct secondary data analysis. Independent samples t-test results indicated there was a significant difference in average total charges between inpatients with 1-4 chronic conditions (CC) and 5+ CC. Chi-square test results showed no association in death during hospitalization among inpatients with 1-4 CC and 5+ CC and also no association between Hispanic and Black race among inpatients with 5+ CC. Despite that these findings showed no significant results in mortality and race, they do support the trend of higher healthcare costs among inpatients with MCC. Given the need to control hospital costs, further exploration of variation in charges and of factors that may be related to MCC among inpatients is recommended. DISCUSSION The results indicated that average total charges for inpatients with 5+ CC were significantly higher than those with 1-4 CC, which complemented previous research. While the Chi-square test results indicated that deaths were higher for inpatients with 5+ CC than 1-4 CC, there was no significant association. Likewise, while 5+ CC was more prevalent among Black inpatients than Hispanic inpatients, there was no significant association. These results were inconsistent with previous research, which indicated a significant association between Hispanic and Black race among patients with MCC. The results in this research may be limited due to a small dataset, which may not have accurately represented the entire population. Inconsistencies may also have been caused by comparing different groups of MCC than previous research. This research grouped MCC into 1-4 CC and 5+ CC, while other research compared groups, such as 2-3 CC and 4+ CC. SAMPLE • Source: Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample (NIS) 2012 - 20% sample of discharges from all inpatient hospitals participating in HCUP (excludes rehabilitation and long term care) • Sampling: random sampling stratified by U.S. Census Division • Data set: randomly selected from NIS 2012 • Project sample limited for assignment - 788 cases with 1+ CC METHODS • Quantitative research using secondary data analysis - data processed using IBM SPSS Version 23 • Descriptive statistics, independent samples t-test, and Chi-square used to analyze data • Confidence level = 95%, alpha level = 0.05 for significance testing S A M P L E / M E T H O D S Friedman, B., & Steiner, C. (2013) Hospital Utilization, Costs, and Mortality for Adults With Multiple Chronic Conditions, Nationwide Inpatient Sample, 2009. Preventing Chronic Disease, 10, E62. Retrieved from http://www.ncbi.nlm.nih.gov.proxy.cc.uic.edu/pmc/articles/PMC3652722 HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). (2012). Agency for Healthcare Research and Quality, Rockville, MD. Retrieved from http://www.hcup-us.ahrq.gov/nisoverview.jsp Jiang H. J., Weiss A.J., Barrett M.L., Sheng M. (2015) Characteristics of Hospital Stays for Super-Utilizers by Payer, 2012. HCUP Statistical Brief #190. Agency for Healthcare Research and Quality, Rockville, MD. Retrieved from http://www.hcup-us.ahrq.gov/reports/statbriefs/sb190-Hospital-Stays-Super- Utilizers-Payer-2012.pdf Steiner C., Barrett M., Weiss A., & Andrews R. (2014) Trends and Projections in Hospital Stays for Adults With Multiple Chronic Conditions (MCC), 2003– 2014. HCUP Statistical Brief #183. Agency for Healthcare Research and Quality. Retrieved from http://www.hcup- us.ahrq.gov/reports/statbriefs/sb183-Hospitalizations-Multiple-Chronic- Conditions-Projections-2014.pdf Ward B. W., & Schiller J. S. (2013) Prevalence of Multiple Chronic Conditions Among US Adults: Estimates From the National Health Interview Survey, 2010. Preventing Chronic Disease, 10. 120203. Retrieved from http://www.cdc.gov/Pcd/issues/2013/12_0203.htm P U R P O S E / H Y P OT H E S E S PURPOSE The purpose of this research is to determine whether there are variations in cost of care and mortality rates among inpatients with multiple chronic conditions (MCC) discharged from acute care hospitals in the U.S. in 2012. This research will also determine if there are racial disparities among inpatients with MCC. RESEARCH QUESTION Are there cost, mortality rate, and race variations among inpatients with MCC? HYPOTHESES • H0: There is no difference in average total charges between inpatients with 1- 4 CC and those with 5 or more CC among discharges from acute care hospitals in the U.S. in 2012. • H1: There is a difference in average total charges between inpatients with 1-4 CC and those with 5 or more CC among discharges from acute care hospitals in the U.S. in 2012. • H0: There is no association in death during hospitalization between inpatients with 1-4 CC and those with 5 or more CC among discharges from acute care hospitals in the U.S. in 2012. • H2: There is an association in death during hospitalization between inpatients with 1-4 CC and those with 5 or more CC among discharges from acute care hospitals in the U.S. in 2012. • H0: There is no association between Hispanic and Black inpatients with 5 or more CC discharged from acute care hospitals in the U.S. in 2012. • H3: There is an association between Hispanic and Black inpatients with 5 or more CC discharged from acute care hospitals in the U.S. in 2012. MCC 1-4, 5+ CC RACE HISPANIC/BLACK DEATH DURING HOSPITALIZATION TOTAL CHARGES MEAN PER GROUP A B S T R A C T M O D E L D I S C U S S I O N / C O N C LU S I O NB A C KG R O U N D R E F E R E N C E S R E S U LT S The prevalence of patients with multiple chronic conditions (MCC) has continuously increased over time and is present in twenty-five percent of Americans adults (Steiner et al., 2014). MCC refers to the existence of two or more chronic conditions that affect a patient simultaneously. The presence of MCC has been seen to impact multiple areas in healthcare, including quality and cost of care. Demographic variations, including race, have also been observed among those with MCC. The following trends were found in previous studies: • Higher healthcare expenditures among those with MCC than those without MCC, contributed by: • Greater percentage of hospital stays • More expensive hospital stays (Steiner et al., 2014) • Higher mortality rates among those with MCC than those without MCC (Friedman & Steiner, 2013) • Higher prevalence of MCC among non-Hispanic black adults compared to Hispanic adults (Ward & Schiller, 2013) These findings are significant as healthcare expenditures among those with MCC have been increasing over time (Steiner et al., 2014). With the continuous increase in patients with MCC, hospital mortality rates may follow the same pattern. Thus, studying these areas may help to find variations among those with MCC. Also, if racial disparities are found, further research can be done to determine their causes. Discovering variations will allow appropriate action to be taken, helping to regulate healthcare costs and patient outcomes. 6 12 0 2 4 6 8 10 12 14 1-4 CC 5+ CC NUMBEROFPATIENTDEATHS $32,416 $44,794 $0 $5,000 $10,000 $15,000 $20,000 $25,000 $30,000 $35,000 $40,000 $45,000 $50,000 1-4 CC 5+ CC AVERAGETOTALCHARGES A V E R A G E T O T A L C H A R G E S P E R G R O U P H I S P A N I C V S . B L A C K I N P A T I E N T S W I T H 5 + C C D E A T H S P E R G R O U P TEST INDEPENDENT SAMPLES T-TEST CHI-SQUARE TEST CHI-SQUARE TEST P-VALUE 0.002 0.317 0.352 RESULT P<0.05, reject H0 P>0.05, fail to reject H0 P>0.05, fail to reject H0 CONCLUSION There is a difference in average total charges between inpatients with 1-4 CC and those with 5+ CC. There is no association in death during hospitalization between inpatients with 1-4 CC and those with 5+ CC. There is no association between Hispanic and Black inpatients with 5 or more CC. 29 49 0 10 20 30 40 50 60 HISPANIC BLACK NUMBEROFPATIENTS A C K N O W L E D G E M E N T S This project was supported by the College of Applied Health Sciences. Special thanks to Professor Valerie Prater, MBA, RHIT, FAHIMA and instructor Shaheen Khan, MS, MBA, MPH. CONCLUSION Overall, the findings in this research were significant despite inconsistencies. This research supported previous findings of a higher cost burden among those with MCC. Costs for patients with MCC are “20 percent more on average” than those without MCC (Steiner et al., 2014). Furthermore, a large proportion of healthcare costs are incurred by a small group of patients, many of which have MCC (Jiang et al., 2015). Thus, it is imperative to find reasons for rising MCC cases as a means to control costs. Despite that this research showed no significant results in mortality and race, further research is recommended. Exploration into the cause of rising MCCs among patients, and into the cost-benefit of continuing reimbursement incentives for documentation of MCCs, present opportunities to reduce growing healthcare expenditures.